Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Penumbra Inc

PEN ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Large Cap Analyst: HOLD

Last Close

$322.17

▲ +0.32%

Market Cap $12.69B · Vol 54.65K

Key Metrics

P/E Ratio

79.13

FWD: 55.79

Market Cap

$12.69B

Large Cap

Div Yield

N/A

EPS Growth

+27.51%

YoY

RSI (14)

37.47

Momentum

Beta

0.70

vs Market

52W High

$362.39

11.10% below

52W Low

$221.28

45.59% above

Volume

54.65K

Avg 86.24K

P/B

8.54

Price-to-book

ROE

11.70%

Return on equity

Free Float

97.05%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Penumbra Inc (PEN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PEN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.15%

-0.63%

+0.48%

-5.14%

YTD

+3.62%

+15.18%

+22.92%

+16.10%

Financials & Valuation

TTM · Annual

Total Revenue	$1.40B
Net Income	$177.69M
Revenue Growth (YoY)	+14.90%
Gross Margin	67.14%
Operating Margin	13.48%
Net Profit Margin	12.66%
ROE	11.70%
ROA · ROIC	12.21% · 13.62%

P/E Ratio	79.13
Forward P/E (FY1)	55.79
PEG Ratio	0.06
P/S	8.70
P/B	8.54
P/FCF	69.83
EPS Growth	+27.51%
Outstanding Shares	39.39M

Technical Indicators

50-Day SMA	$321.15
200-Day SMA	$324.52
RSI (14)	37.47
Beta	0.70
52-Week High	$362.39
52-Week Low	$221.28

Volume Today	54.65K
Avg Daily Volume (30D)	86.24K
Relative Volume	0.63x
Volatility (10D)	5.82
Volatility (30D)	6.28
Free Float	97.05%

Analyst Consensus

HOLD

Current Price $322.17

Mean Target $367.73

52W Low$221.28 52W High$362.39

Current

Target

$221.28 $362.39

Current Analyst target

+14.14% upside potential · 17 analysts

Identifiers

ExchangeNYSE

FIGIBBG001TRHPB0

ISINUS70975L1070

CountryUnited States of America

Sub-IndustryMedical Equipment

Earnings DateNov 3, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

GETI B.ST Getinge publ AB -0.98% MMED MiniMed Group Inc -2.33% 7747.T Asahi Intecc Co Ltd -2.41% 688617.SS APT Medical Inc +3.02% 002223.SZ Jiangsu Yuyue Medical Equipment & Supply Co Ltd +0.51%

Company Profile

Penumbra, Inc. is a thrombectomy company, which is focused on developing technologies for challenging medical conditions, such as ischemic stroke, venous thromboembolism, such as pulmonary embolism, and acute limb ischemia. The Company's broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe. It focuses on developing, manufacturing and marketing novel products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. Some of the conditions it focuses on are Pulmonary Embolism, Deep Vein Thrombosis, Acute Limb Ischemia, Ischemic Stroke, Acute Coronary Syndrome, and Clot associated with Arteriovenous Graft or Fistula. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada, Australia and Singapore, as well as through distributors in select international markets.